ImmuCell Corporation

NASDAQ: ICCC · Real-Time Price · USD
6.09
-0.63 (-9.38%)
At close: Aug 15, 2025, 3:59 PM
6.19
1.64%
After-hours: Aug 15, 2025, 04:10 PM EDT

ImmuCell Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-19.5 -6.79 -18.94 -778.71
PEG Ratio
0.30 -0.05 -0.01 8.41
PS Ratio
1.59 2.24 2.54 3.16
PB Ratio
1.53 1.57 1.56 1.86
P/FCF Ratio
-390.09 -5.97 -8.56 -36.71
P/OCF Ratio
117.52 -8.38 -30.6 63.66
OCF/S Ratio
0.01 -0.27 -0.08 0.05
Debt / Equity Ratio
0.55 0.67 0.41 0.32
Quick Ratio
1.80 0.87 2.59 5.20
Current Ratio
3.41 2.73 4.56 6.42
Asset Turnover
0.59 0.40 0.41 0.43
Interest Coverage
-2.88 n/a -6.6 -7.01
Return on Equity
-0.08 -0.23 -0.08 n/a
Return on Assets
-0.05 -0.13 -0.06 n/a
Return on Invested Capital
-0.04 -0.14 -0.05 -0.06
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.30 0.25 0.41 0.45
Net Profit Margin
-0.08 -0.33 -0.13 -0.00
Pretax Profit Margin
-0.08 -0.33 -0.13 -0.00
Operating Profit Margin
-0.06 -0.33 -0.12 -0.11
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
0.04 -0.14 0.02 0.14